[logo] HealthTree Foundation
search person

HealthTree Foundation Launches New Journaling Feature for Acute Myeloid Leukemia Patients

Posted: Aug 11, 2022
HealthTree Foundation Launches New Journaling Feature for Acute Myeloid Leukemia Patients image

Patients Can Capture and Share Important Parts of Their Disease Journey

As Seen on PR Newswire 

SALT LAKE CITY, UT – August 10, 2022 – The HealthTree Foundation, a patient-driven, 501(c)(3) non-profit organization that empowers patients at each step of their disease journey, today announced the launch of its new journaling feature for multiple myeloma and acute myeloid leukemia patients. The free journaling tool inside of the HealthTree software platform allows patients to capture their stories in video, audio or text format and share journal entries by email or on social media. The journaling addition marks another milestone by the HealthTree Foundation to provide a comprehensive set of tools to blood cancer patients who are navigating a life-threatening diagnosis. Patients can keep the journal entries private or can share the entries with family and friends.

"When I became ill, my wife and I both realized from the many calls, texts and visits that we would not be able to keep up," said AML patient Steve Hodges. Yet, we have so many friends and family who have a genuine need to know what's happening and to support us. We began journaling and providing access for friends and family. Their comments, support, care and interest are a rising tide, bringing us home to those who've meant the most to us over our lifetimes, and who are so good for us now."

The health benefits of journaling are clinically proven to reduce stress, strengthen the immune system, improve memory and comprehension, improve mood and increase emotional regulation.

Journaling is a healing activity for patients for themselves. When journal entries are shared, it can help other patients feel like they aren't alone. 

To access the free journal, click here: 

My AML Journal


About The HealthTree Foundation

The HealthTree Foundation is a patient-driven, 501(c)(3) non-profit organization that empowers patients at each step of their disease journey. Myeloma and AML patients can access the foundation's resources for free. These include the HealthTree Cure Hub, an online community tool that helps patients explore their best treatment options, find clinical trials based on their stage of disease and lab values, and contribute their de-identified data to accelerate a cure. Other HealthTree tools include a learning management platform called HealthTreeUniversity, a HealthTree Coach mentoring program, disease news sites, Community webinar events and a specialist directory. Jennifer Ahlstrom and her husband Paul founded the HealthTree Foundation which provides patient education, advocacy and research funding for multiple myeloma and AML.

Patients Can Capture and Share Important Parts of Their Disease Journey

As Seen on PR Newswire 

SALT LAKE CITY, UT – August 10, 2022 – The HealthTree Foundation, a patient-driven, 501(c)(3) non-profit organization that empowers patients at each step of their disease journey, today announced the launch of its new journaling feature for multiple myeloma and acute myeloid leukemia patients. The free journaling tool inside of the HealthTree software platform allows patients to capture their stories in video, audio or text format and share journal entries by email or on social media. The journaling addition marks another milestone by the HealthTree Foundation to provide a comprehensive set of tools to blood cancer patients who are navigating a life-threatening diagnosis. Patients can keep the journal entries private or can share the entries with family and friends.

"When I became ill, my wife and I both realized from the many calls, texts and visits that we would not be able to keep up," said AML patient Steve Hodges. Yet, we have so many friends and family who have a genuine need to know what's happening and to support us. We began journaling and providing access for friends and family. Their comments, support, care and interest are a rising tide, bringing us home to those who've meant the most to us over our lifetimes, and who are so good for us now."

The health benefits of journaling are clinically proven to reduce stress, strengthen the immune system, improve memory and comprehension, improve mood and increase emotional regulation.

Journaling is a healing activity for patients for themselves. When journal entries are shared, it can help other patients feel like they aren't alone. 

To access the free journal, click here: 

My AML Journal


About The HealthTree Foundation

The HealthTree Foundation is a patient-driven, 501(c)(3) non-profit organization that empowers patients at each step of their disease journey. Myeloma and AML patients can access the foundation's resources for free. These include the HealthTree Cure Hub, an online community tool that helps patients explore their best treatment options, find clinical trials based on their stage of disease and lab values, and contribute their de-identified data to accelerate a cure. Other HealthTree tools include a learning management platform called HealthTreeUniversity, a HealthTree Coach mentoring program, disease news sites, Community webinar events and a specialist directory. Jennifer Ahlstrom and her husband Paul founded the HealthTree Foundation which provides patient education, advocacy and research funding for multiple myeloma and AML.

The author Jennifer Ahlstrom

about the author
Jennifer Ahlstrom

Myeloma survivor, patient advocate, wife, mom of 6. Believer that patients can contribute to cures by joining HealthTree Cure Hub and joining clinical research. Founder and CEO of HealthTree Foundation. 

newsletter icon

Get the latest thought leadership on your Acute Myeloid Leukemia delivered straight to your inbox

Subscribe to the weekly newsletter for news, stories, clinical trial updates, and helpful resources and events with cancer experts.

Thanks to our HealthTree Community for Acute Myeloid Leukemia Sponsors:

Johnson and Johnson
Sanofi
Pfizer
Genentech
Regeneron
Adaptive

Follow Us

facebook instagram youtube